Paydirt
RG
Insider

Renee D Gala

President & CEO · Jazz Pharmaceuticals

Renee D Gala (President & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $486K of JAZZ (2,000 sh × $243.03, as filed), executed Sep 8. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5

Median ADV $210.9M across their filed names

Open performance→
Volume by month
$486K$243K$0Dec 2024Jun 2025Dec 2025Jun 2026Sep 2026 · sells $486KOct 2026 · sells $473KNov 2026 · sells $225K
Buys $0 Sells $1.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
JAZZ Jazz Pharmaceuticals plc JAZZ · 0 buys · 3 sells 3 filings
Recent filings
JAZZSALE Jazz Pharmaceuticals plc View filing → $225K
1,000 sh × $225.37
Exec Nov 3
Filed Nov 5 · 6:28 PM ET
JAZZSALE Jazz Pharmaceuticals plc View filing → $473K
2,000 sh × $236.40
Exec Oct 6
Filed Oct 7 · 5:44 PM ET
JAZZSALE Jazz Pharmaceuticals plc View filing → $486K
2,000 sh × $243.03
Exec Sep 8
Filed Sep 10 · 4:33 PM ET